HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mauro Perretti Selected Research

Annexin A1

1/2022Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis.
1/2022Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.
1/2021Formyl Peptide Receptors and Annexin A1: Complementary Mechanisms to Infliximab in Murine Experimental Colitis and Crohn's Disease.
1/2021Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis.
12/2020Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors.
12/2020Heparan sulfate binds the extracellular Annexin A1 and blocks its effects on pancreatic cancer cells.
1/2020The Annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia.
1/2019Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation.
12/2018Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System.
1/2017The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mauro Perretti Research Topics

Disease

107Inflammation (Inflammations)
01/2022 - 02/2002
22Arthritis (Polyarthritis)
01/2021 - 02/2002
21Peritonitis
11/2020 - 10/2002
9Rheumatoid Arthritis
01/2020 - 04/2002
9Atherosclerosis
01/2020 - 04/2002
9Sepsis (Septicemia)
01/2018 - 10/2009
8Ischemia
11/2017 - 10/2004
8Experimental Arthritis
07/2013 - 02/2002
7Hypersensitivity (Allergy)
01/2022 - 05/2002
7Thrombosis (Thrombus)
01/2021 - 05/2005
7Pain (Aches)
01/2021 - 08/2010
7Reperfusion Injury
01/2019 - 10/2004
6Wounds and Injuries (Trauma)
11/2021 - 03/2015
6Colitis
01/2021 - 11/2002
5Fibrosis (Cirrhosis)
01/2022 - 10/2011
5Neoplasms (Cancer)
12/2020 - 07/2006
5Autoimmune Diseases (Autoimmune Disease)
05/2011 - 03/2009
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 05/2011
4Atherosclerotic Plaque (Atheroma)
01/2021 - 11/2009
4Infarction (Infarctions)
01/2017 - 02/2009
4Edema (Dropsy)
01/2016 - 03/2010
4Obesity
04/2015 - 01/2013
4Gouty Arthritis
04/2011 - 10/2002
3Pneumonia (Pneumonitis)
11/2021 - 12/2008
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 03/2010
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 03/2015
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 12/2018
3Infections
01/2020 - 12/2016
3Hyperalgesia
01/2020 - 05/2014
3Pleurisy (Pleuritis)
01/2019 - 06/2005
3Joint Diseases (Joint Disease)
01/2017 - 01/2011
3Necrosis
02/2015 - 08/2009
3Myocardial Infarction
02/2012 - 01/2005
2Non-alcoholic Fatty Liver Disease
01/2022 - 08/2014
2Crohn Disease (Crohn's Disease)
01/2021 - 01/2013
2Neoplasm Metastasis (Metastasis)
12/2018 - 07/2006

Drug/Important Bio-Agent (IBA)

30Annexin A1IBA
01/2022 - 02/2003
28Peptides (Polypeptides)IBA
01/2022 - 08/2003
27Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2002
20CytokinesIBA
01/2022 - 10/2002
17Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
11/2021 - 11/2003
14MelanocortinsIBA
12/2016 - 10/2002
12ZymosanIBA
01/2019 - 02/2003
12GlucocorticoidsIBA
10/2014 - 02/2002
10LipidsIBA
01/2021 - 01/2013
10AnnexinsIBA
03/2015 - 02/2003
9lipoxin A4IBA
11/2021 - 04/2006
9Pharmaceutical PreparationsIBA
11/2019 - 04/2006
7Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2013
7CarrageenanIBA
01/2017 - 10/2002
7Melanocortin Receptors (Melanocortin Receptor)IBA
08/2014 - 10/2002
71-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
07/2013 - 10/2003
6ChemokinesIBA
01/2022 - 02/2002
6Biological ProductsIBA
12/2014 - 10/2003
6Dexamethasone (Maxidex)FDA LinkGeneric
08/2014 - 10/2002
5LipoxinsIBA
01/2021 - 03/2010
5Uric Acid (Urate)IBA
02/2016 - 02/2006
5Prednisolone (Predate)FDA LinkGeneric
01/2011 - 02/2002
4mesoglycanIBA
11/2021 - 01/2019
4AntigensIBA
01/2020 - 03/2004
4G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020 - 03/2010
4SteroidsIBA
01/2019 - 02/2002
4LigandsIBA
01/2019 - 10/2008
4resolvin D1IBA
01/2018 - 08/2012
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2017 - 11/2002
4Adrenocorticotropic Hormone (ACTH)FDA Link
04/2015 - 10/2002
4Messenger RNA (mRNA)IBA
01/2013 - 10/2004
3Leukocyte Elastase (Neutrophil Elastase)IBA
01/2021 - 06/2013
3Apolipoproteins E (ApoE)IBA
01/2020 - 10/2014
3PhosphatidylserinesIBA
01/2019 - 10/2014
3Interleukin-17 (Interleukin 17)IBA
12/2016 - 03/2009
3EnzymesIBA
10/2014 - 03/2009
3Hormones (Hormone)IBA
08/2014 - 02/2003
3Calcitonin (Calcitonin, Eel)FDA LinkGeneric
08/2014 - 03/2007
3Galectin 1 (LGALS1)IBA
07/2013 - 10/2003
3Galectins (Galectin)IBA
02/2013 - 01/2010
3Interleukin-6 (Interleukin 6)IBA
01/2013 - 12/2010
3Gonadal Steroid Hormones (Sex Hormones)IBA
11/2011 - 02/2003
3Peroxidase (Myeloperoxidase)IBA
09/2010 - 10/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2010 - 12/2002
3Carrier Proteins (Binding Protein)IBA
01/2010 - 10/2003
3prednisolone 21-((4'-nitrooxymethyl)benzoate)IBA
09/2003 - 02/2002
2AllergensIBA
01/2022 - 01/2019
2Urea (Carbamide)FDA LinkGeneric
03/2021 - 03/2009
2Dextran SulfateIBA
01/2021 - 10/2008
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2020 - 06/2013
2Leukotriene B4IBA
11/2020 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2020 - 11/2017
2Neutralizing AntibodiesIBA
01/2020 - 06/2012
2EicosanoidsIBA
01/2019 - 01/2016
2Peptide Hydrolases (Proteases)FDA Link
01/2019 - 11/2012
2IntegrinsIBA
01/2019 - 05/2010
2Nedocromil (Alocril)FDA Link
01/2019 - 01/2011
2Myeloblastin (Proteinase 3)IBA
01/2019 - 06/2013
2CollagenIBA
12/2018 - 02/2015

Therapy/Procedure

22Therapeutics
01/2022 - 02/2007
5Ligation
01/2017 - 10/2009
4Punctures
01/2017 - 10/2009
3Intra-Articular Injections
01/2017 - 03/2004
2Aftercare (After-Treatment)
11/2018 - 01/2011